ArticleDisease models & mechanisms2026
Preserved satellite cell pool in a laminin-α2-deficient model of congenital muscular dystrophy.
Article in Disease models & mechanisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Deficiency in the α2 subunit of laminin-211, encoded by LAMA2, causes congenital LAMA2-related muscular dystrophy (LAMA2 MD), characterized by severe and progressive muscle weakness. In this study, we analyzed muscle regeneration and degeneration in the gastrocnemius muscle of dy2J mice, a model of LAMA2 MD, across different ages. We found that the proportion of satellite cells (SCs) per fiber was significantly higher in the dy2J groups compared to that in the wild-type (WT) group, and that SC numbers did not decrease with disease progression. The percentages of activated SCs, and the expression of Myog and Tgfb, were also significantly elevated in affected animals compared to those in WT animals. Despite the preserved SC pool and their activation, the percentage and diameter of newly regenerated fibers progressively declined as the disease advanced. Histopathological analysis further revealed progressive fiber muscle atrophy. These results suggest that the impairment of muscle regeneration with time in the dy2J model is not due to SC depletion but rather a failure at the later stages of SC differentiation. Further investigation into these processes is essential for developing effective treatment strategies for LAMA2 MD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.